share_log

JMP Securities Downgrades Ambrx Biopharma to Market Perform

JMP Securities Downgrades Ambrx Biopharma to Market Perform

JMP证券将Ambrx Biopharma的评级下调至市场表现
Benzinga ·  01/10 05:23

JMP Securities analyst Reni Benjamin downgrades Ambrx Biopharma (NASDAQ:AMAM) from Market Outperform to Market Perform.

JMP证券分析师雷尼·本杰明将Ambrx Biopharma(纳斯达克股票代码:AMAM)的评级从市场跑赢大盘下调至市场表现。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发